Clinical trial

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

Recruiting now · Not applicable · 1 countries · Registry ID NCT07106879

Recruiting nowNot applicableObservational

What this study is about

DOVE-MET-COME-100 is a single site prescreening survey study designed to identify adults who may be eligible for future industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, current health conditions and symptoms. The study team may also collect basic health information, including vital signs, urine drug tests, blood samples and pregnancy tests (if applicable). A physician will review each participant's medical history in a one-on-one interview to assess potential fit for upcoming trials. If needed, the doctor may contact the participant's current doctors or pharmacies to gather more information for eligibility review.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed

SexAll

Healthy volunteersAccepted

ConditionCardiovascular Diseases, Metabolic Syndrome, Obesity, Prediabetes, Mental Health Disorders, Endocrine Dysfunction, Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease (CKD)

Full registry criteria

Inclusion Criteria: * Any participant of age 18 years and over * Who are willing to provide informed consent and participate in the pre-screening study and comply with study procedures. Exclusion Criteria: * Pregnant or breastfeeding individuals * Individuals having severe cognitive impairment or inability to provide informed consent * Individuals having acute psychiatric emergencies requiring immediate intervention/hospitalization * Individuals who are currently participating in another research study that conflicts with pre-screening data collection * Individuals having known history of drug/alcohol misuse * Individuals having medical conditions that, in the investigator's opinion, could compromise the integrity of the screening process or pose significant risks to the participant's health.

Treatments and study arms

Blood Work

Other

Collection of blood samples for metabolic and other necessary biomarker analysis, including Hemoglobin A1c (HbA1c), Lipid Panel, Liver and Kidney function tests and other protocol-defined assays.

Primary outcomes

Number of participants who express interest in industry-sponsored clinical research5 years

The number of participants who express interest in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, endocrine, metabolic and mental health disorder.

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Clindove Research LLC🇺🇸 Brooklyn, New York, United States

Open map

Nelly Cohen, MDContact

Email · Call 516-518-3239

Nelly Cohen, MDPrincipal Investigator